Pharmaceutical company funding and its consequence...[Contemp Clin Trials. 2008]

SearchDatabase nameforSearch term

Advanced Search (beta)

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 1

Click to change filter selection through MyNCBI.

1: Contemp Clin Trials. 2008 Mar;29(2):109-13. Epub 2007 Aug 16. Links

Pharmaceutical company funding and its consequences: a qualitative systematic review.

Sismondo S.

Department of Philosophy, Queen's University, Kingston, Canada K7L 3N6. sismondo@queensu.ca

This article systematically reviews published studies of the association of pharmaceutical industry funding and clinical trial results, as well a few closely related studies. It reviews two earlier results, and surveys the recent literature. Results are clear: Pharmaceutical company sponsorship is strongly associated with results that favor the sponsors' interests.

PMID: 17919992 [PubMed - indexed for MEDLINE]

Relationship between funding source and conclusion among nutrition-related scientific articles. [PLoS Med. 2007]
Pharmaceutical industry sponsorship and research outcome and quality: systematic review. [BMJ. 2003]
Evaluation of conflict of interest in economic analyses of new drugs used in oncology. [JAMA. 1999]
Industry sponsorship and authorship of clinical trials over 20 years. [Ann Pharmacother. 2004]
Association between pharmaceutical involvement and outcomes in breast cancer clinical trials. [Cancer. 2007]
» See all Related Articles...

Display Show

Pharmaceutical company funding and its consequences: a qualitative systematic review.

Related Articles